These are typically most noticeable in the first few weeks or right after a dose change, and can include nausea, diarrhea, constipation, fatigue, and abdominal pain
Saliva substitutes and oral sprays When your glands are not producing enough saliva, artificial saliva products fill the gap
The longest completed trial is 68 weeks
Common dosing mistakes and how to avoid them After analyzing hundreds of documented retatrutide protocols and community reports, several common mistakes consistently undermine results
The increasing prevalence of obesity and type 2 diabetes mellitus (T2DM) presents a major global health challenge, as many existing therapies lack adequate efficacy and safety. As a triple-action agonist, retatrutide enhances satiety, suppresses hunger and boosts energy expenditure, potentially providing superior benefits for blood sugar control and weight loss compared to other incretin-based therapies
The escalation timeline exists because the trial data showed it produced optimal tolerability and long-term adherence rates
